Clinical Trial Update: Usefulness of Ki67 Index in Hormone Receptor-positive Breast Cancer

View source ↗

Summary

A completed clinical trial from Samsung Medical Center evaluated the usefulness of the Ki67 proliferation index in hormone receptor-positive breast cancer. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Breast Cancer | Status: COMPLETED